Bifidobacterium longum HY8004 attenuates TNBS-induced colitis by inhibiting lipid peroxidation in mice

Inflammation Research

Volumn 59, Issue 5, 2010, Pages 359-368

  Lee, In Ah ^a   Bae, Eun Ah ^a   Lee, Jung Hee ^a,b   Lee, Hoyong ^b   Ahn, Young Tae ^b   Huh, Chul Sung ^b   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Korea Yakult Co   (South Korea)

Author keywords

2,4,6 trinitrobenzene sulfonic acid; Bifidobacterium longum; Inflammatory bowel disease; Lipid peroxidation; NF B; Toll like receptor 4

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MYELOPEROXIDASE; PROBIOTIC AGENT; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM LONGUM; COLITIS; COLON; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; INFLAMMATION; LACTIC ACID BACTERIUM; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFECTIVE AGENTS; BIFIDOBACTERIUM; CELL LINE; COLITIS; COLON; HUMANS; LIPID PEROXIDATION; LIPOSOMES; MALE; MICE; NF-KAPPA B; SULFASALAZINE; TRINITROBENZENESULFONIC ACID;

EID: 77953363389     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-0108-5     Document Type: Article

References (35)

1. Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol. 2004;18: 463-479
2. Berrebi D, Languepin J, Ferkdadji L, Foussat A, De Lagausie P, Paris R, et al. Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr. 2003;37:300-308
3. Carroll IM, Andrus JM, Bruno-Barcena JM, Klaenhammer TR, Hassan HM, Threadgill DS. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismu-tase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol. 2007;293:G353-738.
4. Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol. 2003;201:28-36.
5. Han W, Mercenier A, Ait-Belgnaoui A, Pavan S, Lamine F, van Swam II, et al. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm Bowel Dis. 2006;12:1044-1052
6. Chandran P, Satthaporn S, Robins A, Eremin O. Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II). Surgeon. 2003;1:125-136 (Pubitemid 36758142)
7. Jung HC, Eckmann I, Yang SK, Panja A, Fierer J, Morzycka-Worblewska E, et al. A distinct array of proinflammatory cyto-kine is expressed in human colon epithelia cells in response to bacterial invasion. J Clin Invest. 1995;95:55-65.
8. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipolysaccharide-induced signal transduction. J Biol Chem. 1999;274:10689-10692
9. Cario E, Pldolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000;68: 7010-7017
10. Collins MP, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr. 1999;69:s1052-7.
11. Campieri M, Gionchetti P. Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative. Gastroenterology. 1999;116:1246-1260
12. Perdigon G, de Jorrat WEB, de Petrino SF, Valerde de Budeguer M. Effect of oral administration of Lactobacillus casei on various biological functions of the host. Food Agric Immunol. 1991;3:93-102.
13. Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M, et al. Antidiabetic effect of Lactobacillus GG in streptozo-tocin-induced diabetic rats. Biosci Biotechnol Biochem. 2003;67:1421-1424
14. Taranto MP, Medici M, Perdigon G, Ruiz Holgado AP, Valdez GF. Evidence for hypoglycemic effect of Lactobacillus reuteri in hypercholesterolemic mice. J Dairy Sci. 1998;81:2336-2340
15. Daniel C, Poiret S, Goudercourt D, Dennin V, Leyer G, Pot B. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl Environ Microbiol. 2006;72:5799-5805
16. Peran L, Sierra S, Comalada M, Lara-Villoslada F, Bailon E, Nieto A, et al. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacil-lus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br J Nutr. 2007;97:96-103. (Pubitemid 46662063)
17. Chung YW, Choi JH, Oh TY, Eun CS, Han DS. Lactobacillus casei prevents the development of dextran sulfate sodium-induced colitis in toll-like receptor 4 mutant mice. Clin Exp Immunol. 2007;151:182-189
18. Grabig A, Pcclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, et al. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2-and toll-like receptor 4-dependent pathways. Infect Immun. 2006;74: 4075-4082
19. Peran L, Camuesco D, Comalada M, Bailon E, Henriksson A, Xaus J, et al. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. J Appl Microbiol. 2007;103:836-844 (Pubitemid 47493215)
20. Lee JH, Lee B, Lee HS, Bae EA, Lee H, Ahn YT, et al. Lacto-bacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-jB activation in experimental colitis. Int J Colorectal Dis. 2009;24:231-237
21. Ito M, Ohishi K, Yoshida Y, Yokoi W, Sawada H. Antioxidative effects of lactic acid bacteria on the colonic mucosa of iron-overloaded mice. J Agric Food Chem. 2003;51:4456-4460
22. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085-2088
23. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, et al. Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4). J Exp Med. 1999;1189:615-625
24. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS, et al. Cox-2 is regulated by toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology. 2006;131:862-877
25. Hollenbach E, Vieth M, Rosessner A, Neumann M, Malfertheiner P, Naumann M. Inhibition of RICK/Nuclear factor-kB and p38 signalling attenuates the inflammatory response in a murine model of Crohn disease. J Biol Chem. 2005;280:14981-14988
26. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods. 1985;14:157-167
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;7(2):248-254
28. Ohkawa H, Ohishi N, Yoke K. Assay of lipid peroxidases in animal tissue by thiobarbituric acid reaction. Anal Biochem. 1978;95:351-358
29. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidases. J Lab Clin Med. 1967;701:158-169
30. Prakash A, Medhi B, Avti PK, Saikia UN, Pandhi P, Khanduja KL. Effect of different doses of Manuka honey in experimentally induced inflammatory bowel disease in rats. Phytother Res. 2008;22:1511-1519 (Pubitemid 352789623)
31. Kruis W. Antibiotics and probiotics in inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(suppl. 4):75-78
32. Segúi J, Gironella M, Sans M, Granell S, Gil F, Gimeno M, et al. Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine. J Leukoc Biol. 2004;76:537-544
33. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol. 2005;174:3237-3246
34. Schultz M, Linde HJ, Lehn N, Zimmermann K, Grossmann J, Falk W, et al. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J Dairy Res. 2003;70:165-173
35. Barthet M, Dubucquoy L, Garcia S, Gasmi S, Descreumaux P, Colombel JF, et al. Pancreatic changes in TNBS-induced colitis in mice. Gastroenterol Clin Biol. 2003;27:895-900.